Results 221 to 230 of about 94,256 (324)

Assessing Medication Adherence to Tadalafil 5 mg Once Daily in Erectile Dysfunction: A Cross-Sectional Analysis. [PDF]

Pharmacol Res Perspect
Kandemir E, Kucuktopcu O.
europepmc   +1 more source

Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study [PDF]

, 2001
Joaquim de Almeida Claro, José Elêrton de Aboim, Marcelo Maríngolo, Enrico Andrade, Wilson Aguiar, Marcos Nogueira, Archimedes Nardozza Júnior, Miguel Srougi   +7 more
openalex   +1 more source

Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System

International Journal of Dermatology, EarlyView.
ABSTRACT Background The United States Food and Drug Administration (FDA) approved oral finasteride for androgenetic alopecia. In 2022, approximately 2.6 million U.S. men used it for hair loss and prostate conditions. Post‐finasteride syndrome (PFS), proposed in 2012, involves persistent sexual and neuropsychiatric adverse events (AEs) after cessation ...
Aditya K. Gupta, Mesbah Talukder, Sharon A. Keene, Mary A. Bamimore   +3 more
wiley   +1 more source

Letter to the Editor on "Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction". [PDF]

Sex Med
Selinger S, Thoreson GR.
europepmc   +1 more source

Erectile dysfunction: integrating couple therapy, sex therapy and medical treatment. [PDF]

, 2001
Michael Courtenay
openalex   +1 more source

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ENCORE Study)

International Journal of Urology, EarlyView.
ABSTRACT Objectives Combination therapy of nivolumab‐plus‐ipilimumab has been approved for advanced or metastatic renal cell carcinoma in Japan, but large‐scale clinical data targeting Japanese patients is limited. To evaluate the early outcomes and factors related to early progression and response.
Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka, Shuzo Hamamoto, Masahiro Nozawa, Kazuyuki Numakura, Atsushi Mizokami, Tsunenori Kondo, Sei Naito, Takashige Abe, Kojiro Ohba, Masayoshi Nagata, Shunta Onodera, Hiroaki Ito, Hirotsugu Uemura   +14 more
wiley   +1 more source

Potential utility of the triglyceride-glucose index as a predictor of erectile dysfunction and its severity: a cross-sectional, case-control study. [PDF]

Sci Rep
Ates HA, Bulut TB.
europepmc   +1 more source

Prevalence of undiagnosed diabetes mellitus in male erectile dysfunction

, 2001
Sairam Krishnamurthy, Elena Kulinskaya, G. Boustead, Damian Hanbury, Tom McNicholas   +4 more
openalex   +1 more source

Efficacy of Oral Sildenafil in the Treatment of Erectile Dysfunction in Diabetic Men With Positive Response to Intracavernosal Injection of Alprostadil [PDF]

, 2001
Giuseppe Lepore, I Nosari
openalex   +1 more source

Erectile dysfunction and CVD [PDF]

Nature Reviews Urology, 2010
openaire   +5 more sources